Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1)

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Immunologic research

• Publication date

  1997-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02786321PMID 9048206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage inflammatory protein-1alpha is induced by human immunodeficiency virus infection of monocyte-derived macrophages.

  1996cited by this paper
• A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

  1996cited by this paper
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  1996cited by this paper
• Chemokines and HIV replication

  1996cited by this paper
• HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

  1996cited by this paper
• The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

  1996cited by this paper
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  1996cited by this paper
• Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

  1996cited by this paper
• Molecular cloning and functional expression of a new human CC-chemokine receptor gene.

  1996cited by this paper
• The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation.

  1996cited by this paper
• Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes

  1996cited by this paper
• Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures

  1996cited by this paper
• Regions in β-Chemokine Receptors CCR5 and CCR2b That Determine HIV-1 Cofactor Specificity

  1996cited by this paper
• Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.

  1996cited by this paper
• Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

  1996cited by this paper
• Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

  1996cited by this paper
• A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains

  1996cited by this paper
• Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production

  1996cited by this paper
• CXC Chemokines Bind to Unique Sets of Selectivity Determinants That Can Function Independently and Are Broadly Distributed on Multiple Domains of Human Interleukin-8 Receptor B

  1996cited by this paper
• CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

  1996cited by this paper
• Identification of a major co-receptor for primary isolates of HIV-1

  1996cited by this paper
• Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.

  1996cited by this paper
• HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

  1996cited by this paper
• CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

  1996cited by this paper
• Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages

  1995cited by this paper
• Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins

  1995cited by this paper
• Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

  1995cited by this paper
• Infection, apoptosis, and killing of mature human eosinophils by human immunodeficiency virus-1.

  1995cited by this paper
• V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate

  1995cited by this paper
• Natural protection against HIV-1 infection provided by HIV-2.

  1995cited by this paper
• The Promiscuous Chemokine Binding Profile of the Duffy Antigen/Receptor for Chemokines Is Primarily Localized to Sequences in the Amino-terminal Domain (*)

  1995cited by this paper
• Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus.

  1995cited by this paper
• Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

  1995cited by this paper
• Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

  1995cited by this paper
• Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a – b–) phenotype

  1995cited by this paper
• Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules

  1995cited by this paper
• Interleukin‐10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts

  1995cited by this paper
• The three-dimensional solution structure of RANTES.

  1995cited by this paper
• Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

  1995cited by this paper
• Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism

  1995cited by this paper
• Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

  1995cited by this paper
• Mapping the binding surface of interleukin‐8 complexed with an N‐terminal fragment of the Type 1 human interleukin‐8 receptor

  1994cited by this paper
• Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors.

  1994cited by this paper
• Molecular properties of the chemokine receptor family.

  1994cited by this paper
• The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells

  1994cited by this paper
• Resistance to HIV-1 infection. Multicenter AIDS Cohort Study.

  1994cited by this paper
• High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR.

  1994cited by this paper
• Chemokines, leukocyte trafficking, and inflammation.

  1994cited by this paper
• Resistance to HIV‐1 Infection

  1994cited by this paper
• The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs.

  1994cited by this paper
• Identification of CD7 glycoprotein as an accessory molecule in HIV-1-mediated syncytium formation and cellfree infection.

  1994cited by this paper
• Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes.

  1994cited by this paper
• Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.

  1994cited by this paper
• Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression

  1994cited by this paper
• Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor.

  1993cited by this paper
• Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

  1993cited by this paper
• Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

  1993cited by this paper
• A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells.

  1993cited by this paper
• The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).

  1993cited by this paper
• Chemokines and serpentines: the molecular biology of chemokine receptors

  1993cited by this paper
• Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors.

  1993cited by this paper
• Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen.

  1993cited by this paper
• Interaction between a membrane‐associated serine proteinase of U‐937 monocytes and peptides from the V3 loop of the human immunodeficiency virus type 1 (HIV‐1) gp120 envelope glycoprotein

  1993cited by this paper
• Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: lack of NPY binding and activation.

  1993cited by this paper
• Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS

  1993cited by this paper
• A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor.

  1993cited by this paper
• T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells.

  1993cited by this paper
• Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain.

  1993cited by this paper
• Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite.

  1993cited by this paper
• Importance of the amino terminus of the interleukin-8 receptor in ligand interactions.

  1993cited by this paper
• Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons

  1992cited by this paper
• Long-term symptomless HIV-1 infection in recipients of blood products from a single donor.

  1992cited by this paper
• Sequence Alignment of the G-Protein Coupled Receptor Superfamily

  1992cited by this paper
• Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

  1991cited by this paper
• Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding

  1991cited by this paper
• Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

  1991cited by this paper
• Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus

  1991cited by this paper
• Human immunodeficiency virus infection of eosinophils in human bone marrow cultures

  1991cited by this paper
• Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations.

  1990cited by this paper
• Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells

  1990cited by this paper
• Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations.

  1990cited by this paper
• HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes.

  1989cited by this paper
• Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation.

  1989cited by this paper
• The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

  1986cited by this paper

• RNase P-Associated External Guide Sequences Inhibit HIV-1 Infection by Shutting Down Human CCR5 Expression

  2025cites this paper
• RNase P Ribozyme Effectively Inhibits Human CC-Chemokine Receptor 5 Expression and Human Immunodeficiency Virus 1 Infection

  2023cites this paper
• Functional proteoliposome-like structure derived from simultaneous evisceration and enucleation of T-lymphoblastoid A3R5.7 cells: a Top-Down story.

  2021cites this paper
• Prevalence and Profile of Hepatitis B Virus Infection among HIV-Infected Adults at Panzi Referral Hospital, in the Post-Conflict South Kivu Province, Eastern Democratic Republic of Congo

  2019cites this paper
• Mxra8 is a receptor for multiple arthritogenic alphaviruses

  2018cites this paper
• Discovery of novel anti-HIV agents via Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry-based approach

  2016cites this paper
• Molecular basis for the antagonistic activity of an anti-CXCR4 antibody

  2015cites this paper
• Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue

  2015cites this paper
• Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc.

  2014cites this paper
• Chemokine receptor modeling: an interdisciplinary approach to drug design.

  2014cites this paper
• CXCL12 chemokine and GABA neurotransmitter systems crosstalk and their putative roles

  2014cites this paper
• Biology of Viruses and Viral Diseases

  2014cites this paper
• T Lymphocytes: Helpers

  2013cites this paper
• Baclofen and Other GABAB Receptor Agents Are Allosteric Modulators of the CXCL12 Chemokine Receptor CXCR4

  2013cites this paper
• Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replication.

  2013cites this paper
• Physiology and Pharmacology of Plerixafor

  2013cites this paper
• Investigating Biochemical Interactions Relevant To Human Health Using Backscattering Interferometry

  2013cites this paper
• Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 Replication.

  2012cites this paper
• CCR5 inhibitors: emergence, success, and challenges

  2012cites this paper
• The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor.

  2012cites this paper
• RNase P-Associated External Guide Sequence Effectively Reduces the Expression of Human CC-Chemokine Receptor 5 and Inhibits the Infection of Human Immunodeficiency Virus 1

  2012cites this paper
• Principles of Parasitism

  2011cites this paper
• The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection.

  2011cites this paper
• Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance

  2011cites this paper
• CHAPTER 81 – Human Retroviral Infections in the Tropics

  2011cites this paper
• Inhibition of HIV-1 by fusion inhibitors.

  2010cites this paper
• STUDIES TO UNDERSTAND THE MECHANISM OF HORIZONTAL AND VERTICAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS

  2010cites this paper
• Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication.

  2010cites this paper
• Introduction to Viruses and Viral Diseases

  2010cites this paper
• Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach

  2010cites this paper
• Inhibiting HIV-1 using RNA interference (RNAi) to target novel HIV dependency factors (HDFs)

  2010cites this paper
• [Host genetic factors associated with susceptibility to HIV infection and progression of infection].

  2009cites this paper
• Activation of the spike proteins of alpha- and retroviruses

  2009cites this paper
• Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1.

  2008cites this paper
• Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly

  2008cites this paper
• Infection of Macrophages and Dendritic Cells with Primary R5-Tropic Human Immunodeficiency Virus Type 1 Inhibited by Natural Polyreactive Anti-CCR5 Antibodies Purified from Cervicovaginal Secretions

  2008cites this paper
• A molecular study of the immunopathogenesis of TB spondylitis in HIV -infected and -uninfected patients.

  2008cites this paper
• Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity.

  2007cites this paper
• Declassification of Rodents Exposed to Third-Generation HIV-Based Vectors into Class 1 Animals

  2007cites this paper
• Nanopharmaceutical for improved anti-HIV therapy

  2007cites this paper
• The utility of coreceptor typing in the clinic

  2007cites this paper
• Testing the Efficacy of a Combination of Microwave and Steam Heat for Log Reduction of the Microbial Load following a Simulated Poultry Mass Mortality Event

  2007cites this paper
• Aspects of immune activation in HIV-1 infection

  2007cites this paper
• HIV co-receptor inhibitors as novel class of anti-HIV drugs.

  2006cites this paper
• HIV-positive patients: dental management considerations.

  2006cites this paper
• Human Retroviral Infections in the Tropics

  2006cites this paper
• The multiple roles of p53 in the pathogenesis of HIV associated dementia.

  2005cites this paper
• HIV chemokine receptor inhibitors as novel anti-HIV drugs.

  2005cites this paper
• The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection.

  2004cites this paper
• CD4 and chemokine receptors on human brain microvascular endothelial cells, implications for human immunodeficiency virus type 1 pathogenesis.

  2004cites this paper
• Induction of Intercellular Adhesion Molecule-1 on Human Brain Endothelial Cells by HIV-1 gp120: Role of CD4 and Chemokine Coreceptors

  2003cites this paper
• Is the V3 loop involved in HIV binding to CD4?

  2003cites this paper
• Association of Chemokine-mediated Block to HIV Entry with Coreceptor Internalization*

  2002cites this paper
• Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals

  2001cites this paper
• A Recombinant Virus Assay using Full-length Envelope Sequences to Detect Changes in HIV-1 Co-receptor Usage

  2001cites this paper
• N-Linked Glycosylation Sites Adjacent to and within the V1/V2 and the V3 Loops of Dualtropic Human Immunodeficiency Virus Type 1 Isolate DH12 gp120 Affect Coreceptor Usage and Cellular Tropism

  2001cites this paper
• Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5.

  2000cites this paper
• Assessment of HIV vaccine development: past, present, and future.

  2000cites this paper
• Allelic Distribution of CCR5 and CCR2 Genes in an Italian Population Sample

  2000cites this paper
• HIV‐1 replication in CD4+ T cell lines: the effects of adaptation on co‐receptor use, tropism, and accessory gene function

  2000cites this paper
• Expression and functional characterization of mutant human CXCR4 in insect cells: role of cysteinyl and negatively charged residues in ligand binding.

  2000cites this paper
• Higher Western Blot Immunoreactivity of Glycoprotein 120 from R5 HIV Type 1 Isolates Compared with X4 and X4R5 Isolates

  2000cites this paper
• Simian–Human Immunodeficiency Virus-Associated Nephropathy in Macaques

  2000cites this paper
• Coreceptors for human immunodeficiency virus and simian immunodeficiency virus.

  2000cites this paper
• Characterization of recombinant human CXCR4 in insect cells: role of extracellular domains and N-glycosylation in ligand binding.

  1999cites this paper
• Molluscum contagiosum: its clinical, histopathologic, and immunohistochemical spectrum

  1999cites this paper
• A Genetically Engineered Spleen Necrosis Virus-Derived Retroviral Vector That Displays the HIV Type 1 Glycoprotein 120 Envelope Peptide

  1999cites this paper
• Coreceptor Ligand Inhibition of Fetal Brain Cell Infection by HIV Type 1

  1999cites this paper
• Substitutions in the Receptor-Binding Domain of the Avian Sarcoma and Leukosis Virus Envelope Uncouple Receptor-Triggered Structural Rearrangements in the Surface and Transmembrane Subunits

  1999cites this paper
• Structural biology of HIV.

  1999cites this paper
• Fusion-competent vaccines: broad neutralization of primary isolates of HIV.

  1999cites this paper
• The HIV Coreceptor Repertoire

  1999cites this paper
• Will the genetic individualization of disease force a new paradigm?

  1999cites this paper
• Structural biology of chemokine receptors.

  1999cites this paper
• Identification of determinants of interaction between CXCR4 and gp120 of a dual-tropic HIV-1DH12 isolate.

  1999cites this paper
• Expanded Tropism of Primary Human Immunodeficiency Virus Type 1 R5 Strains to CD4+ T-Cell Lines Determined by the Capacity To Exploit Low Concentrations of CCR5

  1999cites this paper
• Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications.

  1999cites this paper
• Molluscum contagiosum: its clinical, histopathologic, and immunohistochemical spectrum.

  1999cites this paper
• CXCR‐4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells

  1998cites this paper
• CXCR4 as a Functional Coreceptor for Human Immunodeficiency Virus Type 1 Infection of Primary Macrophages

  1998cites this paper
• Introduction: HIV co-receptors solve old questions and raise many new ones.

  1998cites this paper
• HIV Coreceptors

  1998influential citation
• Chapter 27 Genetics and molecular biology of AIDS virus

  1998cites this paper
• Natural Infection of a Homozygous Δ24 CCR5 Red-capped Mangabey with an R2b-Tropic Simian Immunodeficiency Virus

  1998cites this paper
• Potential Contributions of Viral Envelope and Host Genetic Factors in a Human Immunodeficiency Virus Type 1-Infected Long-Term Survivor

  1998cites this paper
• Possible influence of the mutant CCR5 allele on vertical transmission of HIV‐1

  1998cites this paper